PHEL supports rapid HIV tests with timely confirmatory testing using a HIV Western blot test. A testing platform also enables the Virology laboratory to identify cases of HIV-1 and HIV-2
The Sexually Transmitted Disease (STD) Laboratory performs Nucleic Acid Amplification Testing (NAAT) for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. This technology uses the FDA- approved Gen-Probe fully automated TIGRIS Direct Tube System (DTS), which increases testing capacity, decreases specimen contamination, and generates more accurate results with increased sensitivity and specificity. Syphilis serology screening and confirmatory testing are also performed. The STD Laboratory is a key partner and provides testing for the CDC’s Infertility Prevention Program.
Quantiferon-TB (QFT-TB) testing services are available to clinics as an alternative to the current method of testing for latent TB infection (LTBI), the Mantoux tuberculin skin test (TST). This technology offers significant improvement in specificity and sensitivity, decreasing the number of false positives that can lead to misdiagnosis and unnecessary treatment for the patient.
